Normal tissue tolerance dose metrics for radiation therapy of major organs

被引:135
作者
Milano, Michael T.
Constine, Louis S.
Okunieff, Paul
机构
[1] Univ Rochester, Sch Med & Dent, Dept Radiat Oncol, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, James P Wilmot Canc Ctr, Rochester, NY 14642 USA
关键词
D O I
10.1016/j.semradonc.2006.11.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Late organ toxicity from therapeutic radiation is a function of many confounding variables. The total dose delivered to the organ and the volumes of organ exposed to a given dose of radiation are 2 important variables that can be used to predict the risk of late toxicity. Three-dimensional radiation planning enables accurate calculation of the volume of tissue exposed to a given dose of radiation, graphically depicted as a dose-volume histogram. Dose metrics obtained from this 3-dimensional dataset can be used as a quantitative measure to predict late toxicity. This review summarizes the published clinical data on the risk of late toxicity as a function of quantitative dose metrics and attempts to offer suggested dose constraints for radiation treatment planning.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 93 条
[61]  
2-8
[62]   Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis [J].
Marucci, L ;
Niemierko, A ;
Liebsch, NJ ;
Aboubaker, F ;
Liu, MCC ;
Munzenrider, JE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02) :551-555
[63]   PRELIMINARY-RESULTS OF A PILOT-STUDY USING WR-2721 BEFORE FRACTIONATED-IRRADIATION OF THE HEAD AND NECK TO REDUCE SALIVARY-GLAND DYSFUNCTION [J].
MCDONALD, S ;
MEYEROWITZ, C ;
SMUDZIN, T ;
RUBIN, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (04) :747-754
[64]   Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention [J].
Mehta, V .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (01) :5-24
[65]   Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma [J].
Merchant, TE ;
Kiehna, EN ;
Li, CH ;
Shukla, H ;
Sengupta, S ;
Xiong, XP ;
Gajjar, A ;
Mulhern, RK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01) :210-221
[66]   Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy [J].
Münter, MW ;
Karger, CP ;
Hoffner, SG ;
Hof, H ;
Thilmann, C ;
Rudat, V ;
Nill, S ;
Wannenmacher, M ;
Debus, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01) :175-184
[67]   Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer [J].
Narayan, S ;
Henning, GT ;
Ten Haken, RK ;
Sullivan, MA ;
Martel, MK ;
Hayman, JA .
LUNG CANCER, 2004, 44 (01) :79-88
[68]   Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy [J].
Pacholke, HD ;
Amdur, RJ ;
Morris, CG ;
Li, JG ;
Dempsey, JF ;
Hinerman, RW ;
Mendenhall, WM .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (04) :351-358
[69]   Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation [J].
Perez, CA ;
Girgsby, PW ;
Lockett, MA ;
Chao, KSC ;
Williamson, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (04) :855-866
[70]   Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial [J].
Pollack, A ;
Zagars, GK ;
Starkschall, G ;
Antolak, JA ;
Lee, JJ ;
Huang, E ;
von Eschenbach, AC ;
Kuban, DA ;
Rosen, I .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (05) :1097-1105